Megan Finch-Edmondson
Overview
Explore the profile of Megan Finch-Edmondson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
444
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paton M, Benders M, Blatch-Williams R, Dallimore E, Edwards A, Elwood N, et al.
Pediatr Res
. 2025 Jan;
PMID: 39815092
Cell therapies as treatments for neonatal conditions have attracted significant research and parent interest over the last two decades. Mesenchymal stromal cells, umbilical cord blood cells and neural stem cells...
2.
Smith M, Penny T, Pham Y, Sutherland A, Jenkin G, Fahey M, et al.
Cells
. 2023 Nov;
12(22).
PMID: 37998394
(1) Background: Neonatal brain injury can lead to permanent neurodevelopmental impairments. Notably, suppressing inflammatory pathways may reduce damage. To determine the role of neuroinflammation in the progression of neonatal brain...
3.
Novak I, Paton M, Griffin A, Jackman M, Blatch-Williams R, Finch-Edmondson M
Expert Rev Neurother
. 2023 Jul;
23(8):673-675.
PMID: 37428111
No abstract available.
4.
Smith M, Finch-Edmondson M, Miller S, Webb A, Fahey M, Jenkin G, et al.
Stem Cell Res Ther
. 2023 Feb;
14(1):18.
PMID: 36737828
Background: Neural stem cells (NSCs) have the potential to engraft and replace damaged brain tissue, repairing the damaged neonatal brain that causes cerebral palsy (CP). There are procedures that could...
5.
Finch-Edmondson M, Paton M, Honan I, Galea C, Webb A, Novak I, et al.
Pediatrics
. 2023 Jan;
151(2).
PMID: 36695068
Context: Discovering new interventions to improve neurodevelopmental outcomes is a priority; however, clinical trials are challenging and methodological issues may impact the interpretation of intervention efficacy. Objectives: Characterize the proportion...
6.
Paton M, Finch-Edmondson M, Dale R, Fahey M, Nold-Petry C, Nold M, et al.
J Clin Med
. 2022 Dec;
11(24).
PMID: 36555983
Research has established inflammation in the pathogenesis of brain injury and the risk of developing cerebral palsy (CP). However, it is unclear if inflammation is solely pathogenic and primarily contributes...
7.
Finch-Edmondson M, Paton M, Honan I, Karlsson P, Stephenson C, Chiu D, et al.
J Clin Med
. 2022 Dec;
11(24).
PMID: 36555936
Cell therapies are an emergent treatment for cerebral palsy (CP) with promising evidence demonstrating efficacy for improving gross motor function. However, families value improvements in a range of domains following...
8.
Novak I, Te Velde A, Hines A, Stanton E, Namara M, Paton M, et al.
Front Rehabil Sci
. 2022 Oct;
2:726410.
PMID: 36188787
Evidence-based practice is the foundation of rehabilitation for maximizing client outcomes. However, an unacceptably high number of ineffective or outdated interventions are still implemented, leading to sub-optimal outcomes for clients....
9.
Finch-Edmondson M, Hunt R, Nielsen J, Paton M
Front Physiol
. 2022 Sep;
13:994521.
PMID: 36105287
No abstract available.
10.
Te Velde A, Morgan C, Finch-Edmondson M, McNamara L, McNamara M, Paton M, et al.
Pediatrics
. 2022 May;
149(6).
PMID: 35607928
Background And Objective: Bobath therapy, or neurodevelopmental therapy (NDT) is widely practiced despite evidence other interventions are more effective in cerebral palsy (CP). The objective is to determine the efficacy...